Literature DB >> 11306336

Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor.

M Kojima1, H Hosoda, H Matsuo, K Kangawa.   

Abstract

Growth hormone (GH) secretagogues (GHSs) are small synthetic molecules that act through a specific G-protein-coupled receptor (GPCR) called GHS-R. Until the recent identification of 'ghrelin' from rat and human stomachs, GHS-R was an orphan receptor (i.e. had no known natural ligand). Ghrelin is a 28-amino acid peptide with an essential n-octanoyl modification at Ser3. This peptide is found in the secretory granules of X/A-like cells, whose hormonal products and physiological functions have not been previously clarified. The discovery of ghrelin indicates that the release of GH from the pituitary might be regulated not only by hypothalamic GH-releasing hormone, but also by ghrelin derived from the stomach and hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306336     DOI: 10.1016/s1043-2760(00)00362-3

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  86 in total

Review 1.  Ghrelin: the link connecting growth with metabolism and energy homeostasis.

Authors:  Felipe F Casanueva; Carlos Dieguez
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

3.  Abnormal ghrelin secretion in new onset childhood Type 1 diabetes.

Authors:  C Holdstock; J Ludvigsson; F A Karlsson
Journal:  Diabetologia       Date:  2003-11-12       Impact factor: 10.122

4.  Ghrelin and growth hormone: story in reverse.

Authors:  Ralf M Nass; Bruce D Gaylinn; Alan D Rogol; Michael O Thorner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

5.  Ghrelin- and serotonin-producing gastric carcinoid.

Authors:  Eleanor Latta; Fabio Rotondo; Lawrence A Leiter; Eva Horvath; Kalman Kovacs
Journal:  J Gastrointest Cancer       Date:  2012-06

6.  Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.

Authors:  P Cassoni; E Allia; T Marrocco; C Ghè; E Ghigo; G Muccioli; M Papotti
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

7.  Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma.

Authors:  Marcus Mottershead; Emmanuel Karteris; Jill Y Barclay; Saira Suortamo; Mark Newbold; Harpal Randeva; Chuka U Nwokolo
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

8.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

9.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

10.  EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man.

Authors:  F Broglio; F Boutignon; A Benso; C Gottero; F Prodam; E Arvat; C Ghè; F Catapano; A Torsello; V Locatelli; G Muccioli; D Boeglin; V Guerlavais; J A Fehrentz; J Martinez; E Ghigo; R Deghenghi
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.